Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.

Facilitating clinical translation of quantitative imaging techniques has been suggested as means of improving interobserver agreement and diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI) of the prostate. One such technique, magnetic resonance fingerprinting (MRF), has signif...

Full description

Saved in:
Bibliographic Details
Main Authors: Nikita Sushentsev, Joshua D Kaggie, Rhys A Slough, Bruno Carmo, Tristan Barrett
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245970&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850241589405810688
author Nikita Sushentsev
Joshua D Kaggie
Rhys A Slough
Bruno Carmo
Tristan Barrett
author_facet Nikita Sushentsev
Joshua D Kaggie
Rhys A Slough
Bruno Carmo
Tristan Barrett
author_sort Nikita Sushentsev
collection DOAJ
description Facilitating clinical translation of quantitative imaging techniques has been suggested as means of improving interobserver agreement and diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI) of the prostate. One such technique, magnetic resonance fingerprinting (MRF), has significant competitive advantages over conventional mapping techniques in terms of its multi-site reproducibility, short scanning time and inherent robustness to motion. It has also been shown to improve the detection of clinically significant prostate cancer when added to standard mpMRI sequences, however, the existing studies have all been conducted on 3.0 T MRI systems, limiting the technique's use on 1.5 T MRI scanners that are still more widely used for prostate imaging across the globe. The aim of this proof-of-concept study was, therefore, to evaluate the cross-system reproducibility of prostate MRF T1 in healthy volunteers (HVs) using 1.5 and 3.0 T MRI systems. The initial validation of MRF T1 against gold standard inversion recovery fast spin echo (IR-FSE) T1 in the ISMRM/NIST MRI system revealed a strong linear correlation between phantom-derived MRF and IR-FSE T1 values was observed at both field strengths (R2 = 0.998 at 1.5T and R2 = 0.993 at 3T; p = < 0.0001 for both). In young HVs, inter-scanner CVs demonstrated marginal differences across all tissues with the highest difference of 3% observed in fat (2% at 1.5T vs 5% at 3T). At both field strengths, MRF T1 could confidently differentiate prostate peripheral zone from transition zone, which highlights the high quantitative potential of the technique given the known difficulty of tissue differentiation in this age group. The high cross-system reproducibility of MRF T1 relaxometry of the healthy prostate observed in this preliminary study, therefore, supports the technique's prospective clinical validation as part of larger trials employing 1.5 T MRI systems, which are still widely used clinically for routine mpMRI of the prostate.
format Article
id doaj-art-162d2ea3241e4e50bc7e29d388a67500
institution OA Journals
issn 1932-6203
language English
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-162d2ea3241e4e50bc7e29d388a675002025-08-20T02:00:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024597010.1371/journal.pone.0245970Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.Nikita SushentsevJoshua D KaggieRhys A SloughBruno CarmoTristan BarrettFacilitating clinical translation of quantitative imaging techniques has been suggested as means of improving interobserver agreement and diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI) of the prostate. One such technique, magnetic resonance fingerprinting (MRF), has significant competitive advantages over conventional mapping techniques in terms of its multi-site reproducibility, short scanning time and inherent robustness to motion. It has also been shown to improve the detection of clinically significant prostate cancer when added to standard mpMRI sequences, however, the existing studies have all been conducted on 3.0 T MRI systems, limiting the technique's use on 1.5 T MRI scanners that are still more widely used for prostate imaging across the globe. The aim of this proof-of-concept study was, therefore, to evaluate the cross-system reproducibility of prostate MRF T1 in healthy volunteers (HVs) using 1.5 and 3.0 T MRI systems. The initial validation of MRF T1 against gold standard inversion recovery fast spin echo (IR-FSE) T1 in the ISMRM/NIST MRI system revealed a strong linear correlation between phantom-derived MRF and IR-FSE T1 values was observed at both field strengths (R2 = 0.998 at 1.5T and R2 = 0.993 at 3T; p = < 0.0001 for both). In young HVs, inter-scanner CVs demonstrated marginal differences across all tissues with the highest difference of 3% observed in fat (2% at 1.5T vs 5% at 3T). At both field strengths, MRF T1 could confidently differentiate prostate peripheral zone from transition zone, which highlights the high quantitative potential of the technique given the known difficulty of tissue differentiation in this age group. The high cross-system reproducibility of MRF T1 relaxometry of the healthy prostate observed in this preliminary study, therefore, supports the technique's prospective clinical validation as part of larger trials employing 1.5 T MRI systems, which are still widely used clinically for routine mpMRI of the prostate.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245970&type=printable
spellingShingle Nikita Sushentsev
Joshua D Kaggie
Rhys A Slough
Bruno Carmo
Tristan Barrett
Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.
PLoS ONE
title Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.
title_full Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.
title_fullStr Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.
title_full_unstemmed Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.
title_short Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.
title_sort reproducibility of magnetic resonance fingerprinting based t1 mapping of the healthy prostate at 1 5 and 3 0 t a proof of concept study
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245970&type=printable
work_keys_str_mv AT nikitasushentsev reproducibilityofmagneticresonancefingerprintingbasedt1mappingofthehealthyprostateat15and30taproofofconceptstudy
AT joshuadkaggie reproducibilityofmagneticresonancefingerprintingbasedt1mappingofthehealthyprostateat15and30taproofofconceptstudy
AT rhysaslough reproducibilityofmagneticresonancefingerprintingbasedt1mappingofthehealthyprostateat15and30taproofofconceptstudy
AT brunocarmo reproducibilityofmagneticresonancefingerprintingbasedt1mappingofthehealthyprostateat15and30taproofofconceptstudy
AT tristanbarrett reproducibilityofmagneticresonancefingerprintingbasedt1mappingofthehealthyprostateat15and30taproofofconceptstudy